A Phase III, Double-Blind, Placebo-Controlled, Randomized Study Of Ipatasertib In Combination With Atezolizumab And Paclitaxel As A Treatment For Patients With Locally Advanced Unresectable Or Metastatic Triple-Negative Breast Cancer

Kefford, Richard (Primary Chief Investigator)
Chapman, Nicola (Clinical Trial Unit Staff)
Parshionikar, Abhijit (Clinical Trial Unit Staff)
Rajasekharan Nair, Archana (Clinical Trial Unit Staff)

Faculty of Medicine, Health and Human Sciences

Project: Other

Acronym	IPATunity170
Status	Finished
Effective start/end date	22/11/19 → 30/09/24